Home Articles List Article Information
International Journal of Medical Reviews
Journal Archive
Volume Volume 4 (2017)
Volume Volume 3 (2016)
Volume Volume 2 (2015)
Volume Volume 1 (2014)
Isfeedvajani, M. (2017). Cancer Screening Guidelines: A Rapid Review. International Journal of Medical Reviews, 4(4), 95-97. doi: 10.29252/ijmr-040402
Mohsen Saberi Isfeedvajani. "Cancer Screening Guidelines: A Rapid Review". International Journal of Medical Reviews, 4, 4, 2017, 95-97. doi: 10.29252/ijmr-040402
Isfeedvajani, M. (2017). 'Cancer Screening Guidelines: A Rapid Review', International Journal of Medical Reviews, 4(4), pp. 95-97. doi: 10.29252/ijmr-040402
Isfeedvajani, M. Cancer Screening Guidelines: A Rapid Review. International Journal of Medical Reviews, 2017; 4(4): 95-97. doi: 10.29252/ijmr-040402

Cancer Screening Guidelines: A Rapid Review

Article 2, Volume 4, Issue 4, Autumn 2017, Page 95-97  XML PDF (275.64 K)
Document Type: Mini Review
DOI: 10.29252/ijmr-040402
Author
Mohsen Saberi Isfeedvajani
Medicine, Quran and Hadith Research Center and Department of Community Medicine, Faculty of Medicine, Baqiyatallah University of Medical Sciences, Tehran, Iran
Receive Date: 14 October 2017,  Revise Date: 02 November 2017,  Accept Date: 02 December 2017 
Abstract
Cancer is the second leading cause of death worldwide. It has been expected that the burden of cancer has increased due to population growth and aging and lifestyle behaviors. Thus, cancer screening guidelines have developed to prevent mortality and adverse effects of late detection of cancers. In this study, screening guidelines of major cancers have been reviewed and discussed.
Keywords
cancer; Screening; mortality
References
  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7-30. doi: 10.3322/caac.21442. pmid: 29313949.
  2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87-108. doi: 10.3322/caac.21262. pmid: 25651787.
  3. Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015;1(4):505-27. doi: 10.1001/jamaoncol.2015.0735. pmid: 26181261.
  4. Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, et al. Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening. CA Cancer J Clin. 2015;65(1):30-54. doi: 10.3322/caac.21261. pmid: 25581023.
  5. Haas JS, Sprague BL, Klabunde CN, Tosteson AN, Chen JS, Bitton A, et al. Provider Attitudes and Screening Practices Following Changes in Breast and Cervical Cancer Screening Guidelines. J Gen Intern Med. 2016;31(1):52-9. doi: 10.1007/s11606-015-3449-5. pmid: 26129780.
  6. Siu AL, Force USPST. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016;164(4):279-96. doi: 10.7326/M15-2886. pmid: 26757170.
  7. Tonelli M, Connor Gorber S, Joffres M, Dickinson J, Singh H, Lewin G, et al. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ. 2011;183(17):1991-2001. doi: 10.1503/cmaj.110334. pmid: 22106103.
  8. Esherick JS, Clark DS, Slater ED, Gonzales R. Current Practice Guidelines in Primary Care: 2016: McGraw-Hill Medical Publishing Division; 2016.
  9. Sawaya GF, Smith-McCune K. Cervical Cancer Screening. Obstet Gynecol. 2016;127(3):459-67. doi: 10.1097/AOG.0000000000001136. pmid: 26855089.
  10. Fowler CI, Saraiya M, Moskosky SB, Miller JW, Gable J, Mautone-Smith N. Trends in Cervical Cancer Screening in Title X-Funded Health Centers - United States, 2005-2015. MMWR Morb Mortal Wkly Rep. 2017;66(37):981-5. doi: 10.15585/mmwr.mm6637a4. pmid: 28934183.
  11. Leggett BA, Hewett DG. Colorectal cancer screening. Intern Med J. 2015;45(1):6-15. doi: 10.1111/imj.12636. pmid: 25582937.
  12. Bray C, Bell LN, Liang H, Collins D, Yale SH. Colorectal Cancer Screening. WMJ. 2017;116(1):27-33. pmid: 29099566.
  13. Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJ, Young GP, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64(10):1637-49. doi: 10.1136/gutjnl-2014-309086. pmid: 26041752.
  14. Vernon SW, Murphy CC, McQueen A. Colorectal cancer screening. Psycho-Oncology. New York: Oxford University Press; 2015.
  15. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370(14):1287-97. doi: 10.1056/NEJMoa1311194. pmid: 24645800.
  16. Knudsen AB, Zauber AG, Rutter CM, Naber SK, Doria-Rose VP, Pabiniak C, et al. Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies: Modeling Study for the US Preventive Services Task Force. JAMA. 2016;315(23):2595-609. doi: 10.1001/jama.2016.6828. pmid: 27305518.
  17. Sung JJ, Ng SC, Chan FK, Chiu HM, Kim HS, Matsuda T, et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut. 2015;64(1):121-32. doi: 10.1136/gutjnl-2013-306503. pmid: 24647008.
  18. Drazer MW, Huo D, Eggener SE. National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening. J Clin Oncol. 2015;33(22):2416-23. doi: 10.1200/JCO.2015.61.6532. pmid: 26056181.
  19. Catalona WJ. Prostate Cancer Screening. Med Clin North Am. 2018;102(2):199-214. doi: 10.1016/j.mcna.2017.11 .001. pmid: 29406053.
  20. Eastham J. Prostate cancer screening. Investig Clin Urol. 2017;58(4):217-9. doi: 10.4111/icu.2017.58.4.217. pmid: 28681029.
  21. Bibbins-Domingo K, Grossman DC, Curry SJ. The US Preventive Services Task Force 2017 Draft Recommendation Statement on Screening for Prostate Cancer: An Invitation to Review and Comment. JAMA. 2017;317(19):1949-50. doi: 10.1001/jama.2017.4413. pmid: 28397958.
  22. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol. 2014;65(1):124-37. doi: 10.1016/j.eururo.2013.09.046. pmid: 24207135.
  23. Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2017;71(4):618-29. doi: 10.1016/j.eururo.2016.08.003. pmid: 27568654.
  24. de Koning HJ, Meza R, Plevritis SK, ten Haaf K, Munshi VN, Jeon J, et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160(5):311-20. doi: 10.7326/M13-2316. pmid: 24379002.
  25. Tanoue LT, Tanner NT, Gould MK, Silvestri GA. Lung cancer screening. Am J Respir Crit Care Med. 2015;191(1):19-33. doi: 10.1164/rccm.201410-1777CI. pmid: 25369325.
  26. Infante M, Cavuto S, Lutman FR, Passera E, Chiarenza M, Chiesa G, et al. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography. Am J Respir Crit Care Med. 2015;191(10):1166-75. doi: 10.1164/rccm.201408-1475OC. pmid: 25760561.
Statistics
Article View: 128
PDF Download: 97